FPS
AMED

Fieldpoint Private Securities’s Amedisys AMED Stock Holding History

Fieldpoint Private Securities’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$3K Sell
30
-75
-71% -$9.58K ﹤0.01% 1017
2022
Q1 		$18K Buy
105
+40
+62% +$5.98K ﹤0.01% 871
2021
Q4 		$11K Buy
65
+10
+18% +$1.61K ﹤0.01% 1045
2021
Q3 		$8K Hold
55
– – ﹤0.01% 1099
2021
Q2 		$11K Hold
55
– – ﹤0.01% 973
2021
Q1 		$15K Hold
55
– – ﹤0.01% 867
2020
Q4 		$16K Buy
+55
New +$14.1K ﹤0.01% 748

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Fieldpoint Private Securities's AMED Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Amedisys (AMED) stake by 71% in Q2 2022, selling an estimated $9.58K and leaving 30 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

Fieldpoint Private Securities first reported a position in AMED in Q4 2020 and has held it in 7 quarters since. The position peaked at $18K in Q1 2022. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Fieldpoint Private Securities held 30 shares of Amedisys worth $3K as of Q2 2022.
  • Fieldpoint Private Securities sold 75 Amedisys shares in Q2 2022, an estimated $9.58K.
  • Amedisys made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1017 holding.
  • Fieldpoint Private Securities first reported a position in Amedisys in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Amedisys position peaked at $18K in Q1 2022.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.